RMD and NWL: Understanding Valuation Trends in the ASX 100

3 min read | August 06, 2025 11:19 AM AEST | By Team Kalkine Media

Highlights

  • Overview of two leading companies in different sectors
  • How valuation ratios help assess share performance
  • Key insights on industry positioning and growth trends

ResMed CDI (ASX:RMD) and Netwealth Group Ltd (ASX:NWL) are both recognised names in the ASX 100, operating in completely different industries yet drawing significant investor interest. ResMed focuses on healthcare solutions, particularly cloud-connected devices for sleep apnea and respiratory care. Netwealth, on the other hand, operates within the wealth management technology space, offering a digital platform for advisers and investors.

RMD’s Market Position in Healthcare

ResMed has built a strong reputation for its innovative continuous positive airway pressure (CPAP) systems, enabling improved treatment for sleep-related breathing disorders. Its operations extend across numerous countries, supported by a network of advanced medical technology and digital platforms. The company’s software-as-a-service (SaaS) division supports out-of-hospital care, integrating data with device usage to enhance treatment outcomes.

A key consideration for assessing RMD shares lies in comparing its current valuation with its historical norms. Looking at measures such as the price-to-sales ratio offers a general view of how the market is pricing its revenue potential today compared to past years. For RMD, shifts in this ratio can reflect a mix of business growth, revenue changes, and market sentiment.

NWL’s Footprint in Digital Wealth Management

Netwealth has established itself as a prominent player in the financial technology sector, serving a large and growing base of account holders. Its platform simplifies wealth management through a single online dashboard, offering access to investment management tools, performance tracking, and account reporting.

From a valuation perspective, NWL’s current metrics indicate it is trading above its long-term average, suggesting strong market confidence in its platform’s continued growth. However, higher valuations can also mean greater expectations from the market.

Why Valuation Matters

For both companies, valuation ratios like price-to-sales offer an accessible method to gauge whether current share prices align with historical patterns. While these ratios don’t capture every detail of a business’s performance, they provide a helpful starting point for understanding market positioning and potential future movements.

 

Frequently Asked Questions

  • What does the price-to-sales ratio indicate?
    It shows how much investors are willing to pay for each dollar of a company’s revenue, offering a quick snapshot of market valuation.
  • Are RMD and NWL in the same industry?
    No. RMD operates in the medical technology sector, while NWL is in the wealth management technology space.
  • Does being in the ASX 100 impact these companies?
    Yes. Inclusion in the ASX 100 reflects their market capitalisation and prominence, which can attract more institutional attention and liquidity.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.